HopeStage
Back to all studies
CompletedNCT04011280

Smoking Cessation Medication for People With Serious Mental Health Conditions

About this titleRead the official source — NCT04011280
Medication studyAges 18–70United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
La JollaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 12, 2019
Recruitment status
Completed
Enrollment listed in the registry
39
Sponsor
University of California, San Diego
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT04011280
Official title
Show the full official title

Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

La Jolla

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Diego, a university.

Did this study involve medication?

Yes. The study involved medication, including Varenicline.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies